Can epinephrine (adrenaline) 1:1000 (intravenous) be used as a nebulizer in a pediatric patient with stridor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Use of Epinephrine 1:1000 as a Nebulizer for Pediatric Stridor

Yes, epinephrine 1:1000 solution can be used as a nebulizer treatment for pediatric stridor, with a recommended dosage of 0.5 mL/kg up to a maximum of 5 mL. 1

Dosing and Administration

  • Nebulized epinephrine (adrenaline) 1:1000 solution is administered at a dose of 0.5 mL/kg with a maximum dose of 5 mL for treating stridor in children 1
  • For children 4 years and older, the FDA recommends 1 to 3 inhalations not more often than every 3 hours, not exceeding 12 inhalations in 24 hours 2
  • For children under 4 years of age, administration should be supervised by a healthcare provider 2

Clinical Efficacy

  • Nebulized epinephrine produces significant improvement in croup scores at 10 and 30 minutes post-treatment compared to placebo 3, 4
  • The effect is transient, typically lasting 1-2 hours, requiring close monitoring for symptom rebound 1
  • Both racemic epinephrine and L-epinephrine (isomer) are effective, with no significant clinical difference between the two formulations at 30 minutes post-treatment 4

Indications and Clinical Context

  • Primarily indicated for moderate to severe croup with stridor at rest 1, 5
  • Used to avoid intubation and stabilize children prior to transfer to intensive care 1
  • Also effective for post-extubation stridor, showing significant reduction in stridor scores comparable to budesonide 6

Important Precautions

  • The effect of nebulized epinephrine is short-lived (1-2 hours), requiring close monitoring for symptom rebound 1, 5
  • Should not be used in children who are shortly to be discharged or on an outpatient basis due to the risk of rebound symptoms 1, 5
  • Patients should be observed for at least 2-3 hours after the last dose of nebulized epinephrine 5, 7

Combination Therapy

  • Nebulized epinephrine should be used in conjunction with systemic corticosteroids for optimal management of croup 5, 7
  • Oral dexamethasone (0.6 mg/kg) is typically administered alongside nebulized epinephrine 7

Common Pitfalls to Avoid

  • Using IV epinephrine 1:1000 solution for intravenous administration - this concentration should only be used for nebulization or intramuscular injection, never IV 1
  • Discharging patients too early after nebulized epinephrine (before the 2-hour observation period) 5
  • Failing to administer corticosteroids in conjunction with nebulized epinephrine 5
  • Not monitoring for tachycardia, hypertension, or other side effects of epinephrine 6

Discharge Considerations

  • Consider hospital admission if three or more doses of nebulized epinephrine are required 5
  • Patients may be safely discharged after 3 hours of observation if they show sustained response to treatment with nebulized epinephrine plus oral corticosteroids 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Nebulized racemic epinephrine by IPPB for the treatment of croup: a double-blind study.

American journal of diseases of children (1960), 1978

Research

Nebulized epinephrine for croup in children.

The Cochrane database of systematic reviews, 2013

Guideline

Treatment of Croup with Nebulization

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.